Search

Author/Creator Kemper, E Marleen

1. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. (December 2020)

Authors:
Vlaar, Alexander P J; de Bruin, Sanne; Busch, Matthias; Timmermans, Sjoerd A M E G; van Zeggeren, Ingeborg E; Koning, Rutger; ter Horst, Liora; Bulle, Esther B; van Baarle, Frank E H P; van de Poll, Marcel C G; Kemper, E Marleen; van der Horst, Iwan C C; Schultz, Marcus J; Horn, Janneke; Paulus, ...
Journal:
Lancet
Issue:
Volume 2:Number 12(2020)
Page Start:
e764
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. DDRE-32. ABC TRANSPORTERS RESTRICT THE BRAIN PENETRATION AND INTRACRANIAL EFFICACY OF ANTICANCER AGENTS EVEN WHEN BLOOD-BRAIN BARRIER INTEGRITY IS LOST. (9th November 2020)

Authors:
de Gooijer, Mark C; Kemper, E Marleen; Buil, Levi C M; Çitirikkaya, Ceren H; Buckle, Tessa; Beijnen, Jos H; van Tellingen, Olaf
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 2
Page Start:
ii68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial. Issue 9 (September 2021)

Authors:
Aman, Jurjan; Duijvelaar, Erik; Botros, Liza; Kianzad, Azar; Schippers, Job R; Smeele, Patrick J; Azhang, Sara; Bartelink, Imke H; Bayoumy, Ahmed A; Bet, Pierre M; Boersma, Wim; Bonta, Peter I; Boomars, Karin A T; Bos, Lieuwe D J; van Bragt, Job J M H; Braunstahl, Gert-Jan; Celant, Lucas R; Eger,...
Journal:
Lancet
Issue:
Volume 9:Issue 9(2021)
Page Start:
957
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search